StockData
Ocugen, Inc. logo

Ocugen, Inc. (OCGN) stock

OCGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 1/30
$0.74−0.02 (-2.31%)

Close on Nov 18, 2026Market cap $250.67MP/E –Yield –

Ocugen net income

Net income is the profit left for shareholders after every expense, interest and tax.

Ocugen's net income for the twelve months ending Jun 30, 2026 was -$81.81M. For fiscal 2025 it was -$67.85M. The highest annual figure on record is -$16.21M in fiscal 2016.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$67.85M–
FY2024Dec 31, 2024-$54.05M–
FY2023Dec 31, 2023-$63.08M–
FY2022Dec 31, 2022-$86.80M–
FY2021Dec 31, 2021-$58.37M–
FY2020Dec 31, 2020-$21.82M–
FY2019Dec 31, 2019-$20.24M–
FY2018Dec 31, 2018-$18.22M–
FY2017Dec 31, 2017-$26.41M–
FY2016Dec 31, 2016-$16.21M–
FY2015Dec 31, 2015-$32.02M–
FY2014Dec 31, 2014-$22.79M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$24.88M–
Q1 FY2026Mar 31, 2026-$19.18M–
Q4 FY2025Dec 31, 2025-$17.71M–
Q3 FY2025Sep 30, 2025-$20.05M–
Q2 FY2025Jun 30, 2025-$14.74M–
Q1 FY2025Mar 31, 2025-$15.35M–
Q4 FY2024Dec 31, 2024-$13.88M–
Q3 FY2024Sep 30, 2024-$12.97M–
Q2 FY2024Jun 30, 2024-$15.28M–
Q1 FY2024Mar 31, 2024-$11.92M–
Q4 FY2023Dec 31, 2023-$10.97M–
Q3 FY2023Sep 30, 2023-$11.72M–
Q2 FY2023Jun 30, 2023-$23.07M–
Q1 FY2023Mar 31, 2023-$17.33M–
Q4 FY2022Dec 31, 2022-$22.39M–
Q3 FY2022Sep 30, 2022-$23.91M–
Q2 FY2022Jun 30, 2022-$21.48M–
Q1 FY2022Mar 31, 2022-$19.02M–
Q4 FY2021Dec 31, 2021-$14.58M–
Q3 FY2021Sep 30, 2021-$10.76M–
Q2 FY2021Jun 30, 2021-$25.95M–
Q1 FY2021Mar 31, 2021-$7.08M–
Q4 FY2020Dec 31, 2020-$3.79M-130.6%
Q3 FY2020Sep 30, 2020-$10.47M–
Q2 FY2020Jun 30, 2020-$3.61M–
Q1 FY2020Mar 31, 2020-$3.94M–
Q4 FY2019Dec 31, 2019$12.38M–
Q3 FY2019Sep 30, 2019-$22.77M–
Q2 FY2019Jun 30, 2019-$3.54M–
Q1 FY2019Mar 31, 2019-$6.31M–
Q4 FY2018Dec 31, 2018-$5.96M–
Q3 FY2018Sep 30, 2018-$1.93M–
Q2 FY2018Jun 30, 2018-$5.29M–
Q1 FY2018Mar 31, 2018-$5.04M–
Q4 FY2017Dec 31, 2017-$6.80M-175.0%
Q3 FY2017Sep 30, 2017-$6.00M–
Q2 FY2017Jun 30, 2017-$6.54M–
Q1 FY2017Mar 31, 2017-$7.08M–
Q4 FY2016Dec 31, 2016$9.06M–
Q3 FY2016Sep 30, 2016-$9.32M–

More Ocugen figures

See a number that looks wrong?